Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease

• Hoofdauteurs: Marianna Lucafò (Auteur), Debora Curci (Auteur), Matteo Bramuzzo (Auteur), Patrizia Alvisi (Auteur), Stefano Martelossi (Auteur), Tania Silvestri (Auteur), Veronica Guastalla (Auteur), Flavio Labriola (Auteur), Gabriele Stocco (Auteur), Giuliana Decorti (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Introduction: Adalimumab is effective in inducing and maintaining remission in children with inflammatory bowel diseases (IBD). Therapeutic drug monitoring is an important strategy to maximize the response rates, but data on the association of serum adalimumab levels are lacking. This study aimed to...